Pais / Región
Paises

Provincias / Departamentos
Colombia Colombia
Argentina Argentina
Canada Canada
Chile Chile
Ecuador Ecuador
España España
Guatemala Guatemala
Honduras Honduras
Mexico Mexico
Panama Panama
Paraguay Paraguay
United States United States
Uruguay Uruguay
Categorias / Industrias
Publication: 0000-00-00 00:00:00
United States SAM

Laboratory Reagent Requirements for U.S. Naval Hospital (USNH) Yokosuka, Japan

Process Number DLATSP-22-SS-0003

USA

Dates:


Notice ID:

DLATSP-22-SS-0003

Department/Ind. Agency:

DEPT OF DEFENSE

Sub-tier:

DEPT OF DEFENSE

Sub Command:

DLA TROOP SUPPORT INDO-PACIFIC

Office:

DLA TROOP SUPPORT INDO-PACIFIC

General Information:


All Dates/Times are:

(utc+09:00) tokyo, japan

Updated Published Date:

(utc+09:00) tokyo, japan

Original Published Date:

0000-00-00 00:00:00

Original Response Date:

feb 11, 2022 11:00 am jst

Inactive Policy:

15 days after response date

Initiative:
  • None***--***

Classification:


Product Service Code:

6515 - medical and surgical instruments, equipment, and supplies

NAICS Code:

325413 - in-vitro diagnostic substance manufacturing

Description:


Original Set Aside:

This is only a sources sought announcement and not an intent to procure. A solicitation is not available at this time and any requests for a solicitation will not receive a response. The Defense Logistics Agency (DLA) Troop Support Indo-Pacific is conducting a market research to identify local sources capable and interested in fulfilling a requirement for the procurement and delivery of CLASS VIII, Medical supplies in support of United States Naval Hospital (USNH), located in Yokosuka, Japan. The responses to this sources sought synopsis will be used to make appropriate acquisition decisions for the next procurement phase. After review of the responses submitted regarding this potential acquisition, a solicitation announcement may be published in SAM.gov if and when the Government intends to continue with the procurement. The applicable North American Industry Classification System (NAICS) code is 325413 In-Vitro Diagnostic Substance Manufacturing. This U.S. industry comprises establishments primarily engaged in manufacturing in-vitro (i.e., not taken internally) diagnostic substances, such as chemical, biological, or radioactive substances. The substances are used for diagnostic tests that are performed in test tubes, petri dishes, machines, and other diagnostic test-type devices. DLA Troop Support Pacific contemplates a Firm-Fixed Priced Indefinite Delivery, Indefinite Quantity type contract for a base period of 12 months, first option period 12 months, second option period 12 months, estimated under $650,000.00; which is inclusive of shipping and delivery. THIS SOURCES SOUGHT ANNOUNCEMENT IS FOR INFORMATIONAL AND MARKET RESEARCH PURPOSES ONLY. THIS NOTICE DOES NOT CONSTITUTE A SOLICITATION AND SHALL NOT BE CONSTRUED AS A COMMITMENT BY THE U.S. GOVERNMENT. THE U.S. GOVERNMENT IS UNDER NO OBLIGATION TO AWARD A CONTRACT AS A RESULT OF THIS ANNOUNCEMENT. ALL INFORMATION SUBMITTED IN RESPONSE TO THIS ANNOUNCEMENT IS VOLUNTARY The Government will not pay for any materials furnished in response to this notice. Submittals furnished will not be returned to the sender. Responses must be received no later than 11:00 a.m. Japan Standard Time Friday, 11 February 2022. Please submit all information via email to ryan.spahr@dla.mil and gilbert.mincey@dla.mil

Attachments / Links:


Document Size Updated date Download

Contact Information:


1025 QUINCY AVE, SUITE 1000

JBPHH , HI 96860-3520

USA

Primary Point of Contacts:

Ryan Spahr

Secondary Point of Contact:

Gilbert Mincey